Suppr超能文献

羧甲基纤维素与羟丙基甲基纤维素泪液替代品治疗计算机视觉综合征所致干眼的疗效与安全性比较

Carboxymethyl Cellulose versus Hydroxypropyl Methylcellulose Tear Substitutes for Dry Eye Due to Computer Vision Syndrome: Comparison of Efficacy and Safety.

作者信息

Rajendraprasad Rahul M, Kwatra Gagandeep, Batra Nitin

机构信息

Medical Advisor, Novo Nordisk India, Bengaluru, Karnataka, India.

Department of Pharmacology, Christian Medical College and Hospital, Ludhiana, Punjab, India.

出版信息

Int J Appl Basic Med Res. 2021 Jan-Mar;11(1):4-8. doi: 10.4103/ijabmr.IJABMR_399_20. Epub 2021 Jan 26.

Abstract

BACKGROUND

Prolonged use of visual display terminal images on electronic devices such as computers frequently leads to symptoms of dry eye. Tear substitutes form the mainstay of treatment for mild-to-moderate dry eye.

AIM

The study aimed to evaluate the efficacy and safety of carboxymethyl cellulose (CMC) versus hydroxypropyl methylcellulose (HPMC) tear substitutes for dry eye due to computer vision syndrome (CVS).

MATERIALS AND METHODS

This was a prospective, randomized, comparative, and open-labeled study. The efficacy of CMC 0.5% and HPMC 0.3% tear substitutes was compared in 180 participants (90 in each group) with dry eye. Change in Ocular Surface Disease Index (OSDI) score, Schirmer I test score, and tear film break up time (TF-BUT) were used as efficacy parameters. Safety was monitored on all visits.

RESULTS

The baseline OSDI score? 23.48 and 23.32 in Group A and B, respectively, decreased with treatment in both groups on all follow-up visits as compared to the baseline (day 90: 13.9 ± 3 vs. 14.81 ± 3.17, : 0.01). The scores of Schirmer I test increased in both groups, with a greater improvement in Group A (at day 90: 22.75 ± 3.04 mm vs. 21.78 ± 3.36 mm, : 0.04). The values of TF-BUT improved in both groups, the difference being statistically insignificant. An initial stinging was reported by one participant, each in both groups.

CONCLUSION

CMC and HPMC tear substitutes were equally efficacious and safe in reducing symptoms of dry eye due to CVS.

摘要

背景

长时间使用电脑等电子设备上的视觉显示终端图像经常会导致干眼症状。泪液替代物是轻至中度干眼治疗的主要手段。

目的

本研究旨在评估羧甲基纤维素(CMC)与羟丙基甲基纤维素(HPMC)泪液替代物治疗因电脑视觉综合征(CVS)导致的干眼的疗效和安全性。

材料与方法

这是一项前瞻性、随机、对照、开放标签研究。比较了180例干眼患者(每组90例)使用0.5% CMC和0.3% HPMC泪液替代物的疗效。采用眼表疾病指数(OSDI)评分、泪液分泌试验Ⅰ(Schirmer I)评分和泪膜破裂时间(TF-BUT)的变化作为疗效参数。每次随访时均监测安全性。

结果

A组和B组的基线OSDI评分分别为23.48和23.32,与基线相比,两组在所有随访时的治疗后评分均降低(第90天:13.9±3对14.81±3.17,P<0.01)。两组Schirmer I试验评分均升高,A组改善更明显(第90天:22.75±3.04 mm对21.78±3.36 mm,P<0.04)。两组TF-BUT值均改善,差异无统计学意义。两组各有1例参与者报告最初有刺痛感。

结论

CMC和HPMC泪液替代物在减轻因CVS导致的干眼症状方面同样有效且安全。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c2f/8025960/9854d72b045f/IJABMR-11-4-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验